Association of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample

scientific article

Association of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2012PLoSO...729228A
P356DOI10.1371/JOURNAL.PONE.0029228
P932PMC publication ID3256145
P698PubMed publication ID22247771
P5875ResearchGate publication ID221750011

P50authorDoron LancetQ6746048
Fabio MacciardiQ30347913
P2093author name stringSara Lupoli
Bernard Lerer
Edna Ben-Asher
Anna Alkelai
Lior Greenbaum
Yoav Kohn
Kyra Sarner-Kanyas
P2860cites workGenome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in womenQ21145218
RETRACTED: Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic isletsQ24302717
Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sampleQ24540539
PLINK: a tool set for whole-genome association and population-based linkage analysesQ24677407
Identification of the substrates for plasma hyaluronan binding proteinQ28202045
AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophreniaQ28245905
The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitusQ28286017
A genome-wide association study identifies novel risk loci for type 2 diabetesQ28287727
TCF4 deficiency expands ventral diencephalon signaling and increases induction of pituitary progenitorsQ28505384
Effects of canonical Wnt signaling on dorso-ventral specification of the mouse telencephalonQ28592524
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variantsQ29547210
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetesQ29614589
Genome-wide scan in 124 Indonesian sib-pair families with schizophrenia reveals genome-wide significant linkage to a locus on chromosome 3p26-21.Q30843112
A pedigree series for mapping disease genes in bipolar affective disorder: sampling, assessment, and analytic considerationsQ72105571
Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sampleQ73307645
TCF7L2 polymorphisms are associated with type 2 diabetes in northern SwedenQ79634107
Evidence for an interaction of schizophrenia susceptibility loci on chromosome 6q23.3 and 10q24.33-q26.13 in Arab Israeli familiesQ83201490
Expression and molecular diversity of Tcf7l2 in the developing murine cerebellum and brainQ44819480
Metabolic risk factors in drug-naive patients with first-episode psychosis.Q45982515
Diabetes and schizophrenia - effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia.Q46727955
Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study.Q51591321
At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia.Q51808997
Susceptibility locus on chromosome 1q23-25 for a schizophrenia subtype resembling deficit schizophrenia identified by latent class analysis.Q51862599
Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24.Q51948252
Testing for genetic association between the ZDHHC8 gene locus and susceptibility to schizophrenia: An integrated analysis of multiple datasets.Q53071447
Association of histone deacetylase genes with schizophrenia in Korean population.Q53470727
Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance.Q53602883
Identification of new schizophrenia susceptibility loci in an ethnically homogeneous, family-based, Arab-Israeli sampleQ57016397
Trends in the frequencies of consanguineous marriages in the Israeli Arab communityQ57102580
Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolutionQ57278407
Support for involvement of the AHI1 locus in schizophreniaQ57309509
Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and womenQ58879642
A genome-wide investigation of SNPs and CNVs in schizophreniaQ33406258
Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysisQ33410679
Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control studyQ33430488
Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associationsQ33549716
Association study of genetic variants in eight genes/loci with type 2 diabetes in a Han Chinese populationQ33605321
Impact of the AHI1 gene on the vulnerability to schizophrenia: a case-control association studyQ33678807
Evidence for neuroendocrine function of a unique splicing form of TCF7L2 in human brain, islets and gut.Q33696621
A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophreniaQ33727503
The architecture of gene regulatory variation across multiple human tissues: the MuTHER studyQ33815387
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profilesQ34006864
Expression of the diabetes-associated gene TCF7L2 in adult mouse brainQ34252656
Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2.Q34469246
Replication of genetic variants from genome-wide association studies with metabolic traits in an island population of the Adriatic coast of CroatiaQ34705195
Research diagnostic criteria: rationale and reliabilityQ34711463
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention ProgramQ35568877
Nucleus- and cell-specific gene expression in monkey thalamusQ35613712
Excitement and confusion on chromosome 6q: the challenges of neuropsychiatric genetics in microcosmQ36261628
Diabetes and schizophrenia 2005: are we any closer to understanding the link?Q36310303
Illumina universal bead arraysQ36580123
Replication study of candidate genes associated with type 2 diabetes based on genome-wide screeningQ37066951
Power calculations for a general class of family-based association tests: dichotomous traitsQ37218960
Meta-analysis of 32 genome-wide linkage studies of schizophrenia.Q37274086
Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorderQ37365437
Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug actionQ37633791
Genetic variation of regulatory systemsQ37635538
Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophreniaQ37770196
Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes.Q37787421
Structure-function analysis of factor VII activating protease (FSAP): sequence determinants for heparin binding and cellular functionsQ39850743
Prevalence of diabetes in patients with schizophrenia in Taiwan: a population-based National Health Insurance studyQ39882923
Genetic association between 5'-upstream single-nucleotide polymorphisms of PDGFRB and schizophrenia in a Korean populationQ40082891
TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysisQ40216751
Illumina, Inc.Q40383423
A systematic genomewide linkage study in 353 sib pairs with schizophreniaQ41966061
The balance of TCF7L2 variants with differential activities in Wnt-signaling is regulated by lithium in a GSK3beta-independent mannerQ42006583
PBAT: a comprehensive software package for genome-wide association analysis of complex family-based studies.Q42064007
Candidate gene association study conditioning on individual ancestry in patients with type 2 diabetes and metabolic syndrome from Mexico City.Q43054068
Further investigation of the association between rs7341475 and rs17746501 and schizophreniaQ43063602
Meta-analysis of association between genetic variants in COMT and schizophrenia: an updateQ43686229
The family history method using diagnostic criteria. Reliability and validityQ44578310
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectIsraelQ801
schizophreniaQ41112
type 2 diabetesQ3025883
P304page(s)e29228
P577publication date2012-01-11
P1433published inPLOS OneQ564954
P1476titleAssociation of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample
P478volume7

Reverse relations

cites work (P2860)
Q45632870Assessment of cardiovascular disease risk in patients with schizophrenia spectrum disorders in German psychiatric hospitals: results of the pharmacoepidemiologic CATS study
Q37686203Bernard Lerer: recipient of the 2014 inaugural Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine (Pacific Rim Association for Clinical Pharmacogenetics).
Q38709352Diabetes and Schizophrenia
Q36826582Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia
Q26752342Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity
Q30458875Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis
Q41159260Genetic Background Limits Generalizability of Genotype-Phenotype Relationships
Q46884539Genetic association study between the detected risk variants based upon type II diabetes GWAS and psychotic disorders in the Japanese population
Q47891942Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits
Q38763079Implementation successes and challenges in participating in a pragmatic study to improve colon cancer screening: perspectives of health center leaders
Q36100608Integrative approach for inference of gene regulatory networks using lasso-based random featuring and application to psychiatric disorders
Q37176819Metabolic syndrome in schizophrenia: theoretical, clinical and translational perspectives
Q36298817Microarray Analysis of Human Blood During Electroconvulsive Therapy
Q36944916Molecular anatomy of the thalamic complex and the underlying transcription factors
Q84553598No association between the type 2 diabetes mellitus susceptibility gene, SLC30A8 and schizophrenia in a Chinese population
Q34479682Novel β-catenin target genes identified in thalamic neurons encode modulators of neuronal excitability
Q30248914Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs
Q38078834Physiological role of β-catenin/TCF signaling in neurons of the adult brain
Q37301034Postnatal isoform switch and protein localization of LEF1 and TCF7L2 transcription factors in cortical, thalamic, and mesencephalic regions of the adult mouse brain
Q38469831Promoting physical health for people with schizophrenia by reducing disparities in medical and dental care.
Q38057999TCF4 (e2-2; ITF2): a schizophrenia-associated gene with pleiotropic effects on human disease
Q33709807TCF7L2 polymorphisms and the risk of schizophrenia in the Chinese Han population
Q91062894TCF7L2 polymorphisms are associated with amygdalar volume in elderly individuals with Type 2 Diabetes
Q53689686The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance.
Q30557277The ventral habenulae of zebrafish develop in prosomere 2 dependent on Tcf7l2 function
Q34658275Wnt signaling and the control of human stem cell fate.
Q92892451Wnt/β-catenin signaling in brain development and mental disorders: keeping TCF7L2 in mind

Search more.